Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Biosimilar Development

Biologic therapeutics have revolutionized the treatment of cancer and immune-mediated inflammatory diseases. As patent protections on innovator biologics expire, global drug manufacturers are ramping up the development of follow-on drugs known as biosimilars. These therapeutic agents are highly similar to the original patented biologic in structure and function.

The process of manufacturing innovator biologic and biosimilar drugs is complex and variable; thus robust characterization tools are needed. Biosimilar development, in particular, requires extensive analytical comparison of drug structure and function to ensure biosimilarity to the reference product. We offer a variety of analytical tools that enable drug developers to bring these biosimilar products to market, thereby ensuring patient access to high-quality, cost-effective therapeutics.

Lessons from HSV and SARS-CoV-2 vaccine development. Free webinar.

Filter By

Product Type

Shop All Biosimilar Development Tools

Showing 22 of 22 Products